Bracco Diagnostics Inc. Showcases Innovations and More at RSNA 2024 Annual Meeting
Bracco is propelling radiology forward through innovation, education, sustainability, and trust
Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., a leading global company in the diagnostic imaging business, is showcasing its purpose-driven approach and cutting-edge innovations across all imaging modalities at the Radiological Society of North America (RSNA) 2024 Annual Meeting, to be held December 1-5 in Chicago, Illinois. This year, Bracco’s activities at RSNA are captured by the theme, “Our journey to the future continues today, together”—underscoring Bracco’s commitment to partnering with its customers to advance the practice of radiology.
Demonstrating Innovation in Practice at RSNA 2024
VUEWAY® (gadopiclenol) solution for injection, a macrocyclic gadolinium-based contrast agent (GBCA) is about to achieve its millionth dose. VUEWAY® injection offers effective contrast enhancement at half the gadolinium (Gd) dose (0.05 mmol/kg) vs. a macrocyclic GBCA at a dose of 0.1 mmol/kg of other similar contrast media for approved indications in the U.S.,1 which can help address the unmet medical need to minimize Gd exposure per MRI procedure and reduce the overall lifetime dose.
Ryan Murtagh, MD, Chief of Neuroradiology at Tampa General Hospital and Tampa General Hospital Imaging, said, "Since we started using the VUEWAY (gadopiclenol) solution for injection in February 2023, our experience has been exceptional. We are excited about delivering half the gadolinium compared to other approved macrocyclic agents in the U.S. VUEWAY injection has significantly given us the ability to reduce the gadolinium dose for our patients without compromising image quality. The Bracco team helped make the transition seamless, and our patients appreciate the reduced dose of gadolinium. We are very happy with the results."
Beyond VUEWAY injection, the Bracco MR portfolio will further expand its offering at RSNA 2024 with the two recently FDA-cleared solutions:
- AiMIFYTM is the new solution for AI-powered contrast enhancement in MR imaging in the U.S. exclusively from Bracco and Subtle Medical. It recently received FDA clearance as a class II software as a medical device and it is intended for image enhancement in brain MRI. AiMIFYTM amplifies image contrast enhancement up to two times the level obtained with a labeled dose of a GBCA, significantly improving the visibility of small and large lesions compared to standard post-contrast images.2 For more information, visit the Bracco booth #3300 and the Subtle Medical booth #4739 in the South Hall, Level 3.
- Bracco is proud to offer the Max 3TM, a Rapid Exchange and Syringeless MR Injector that recently received FDA 510(k) clearance and is a first of its kind in the MRI space, empowering intuitive, efficient, and easy-to-manage workflow and supporting best practices in radiology sustainability.
Products Looking to the Future, Across all Modalities
Bracco supports its customers with the highest level of service, science, and breadth of innovative products across all modalities. Don’t miss out on the following innovations at RSNA 2024:
- Bracco’s contrast-enhanced ultrasound contrast agent offers a wide range of indications in cardiology and radiology that can be added to practitioners’ diagnostic tools. Bracco is leading in expanding access to these contrast agents for radiologists by driving innovation with ultrasound original equipment manufacturers.
- In support of abdominal imagers, Bracco is proud to have launched CitraClearTM, the gutsy-filling beverage, that will be available for a taste test at the BDI booth.
- Learn about Bracco's new partnership with ColoWatch® which makes implementing a Virtual Colonoscopy (VC) practice for imaging centers easy. With the recent U.S. Centers for Medicare and Medicaid Services recommendation that proposes Medicare reimbursement for colorectal cancer screening using VC, radiology can play an even bigger role in saving lives.
Driving Sustainability Forward
Bracco recently won the EcoVadis Gold Medal Sustainability Award for the second year in a row for its accomplishments in the environment, ethics, labor and human rights, and sustainable procurement. This award puts Bracco in the top 5% of the 100,000 global companies certified by EcoVadis, the world’s largest and most trusted provider of business sustainability ratings.
Bracco also has multiple initiatives in packaging, product development, and upcoming product launches grounded in sustainability as their guiding principle.
Supporting the Growth of Radiology
Bracco is dedicated to advancing the field of radiology by sharing knowledge to build expertise. The company remains committed to fostering the exchange of expertise with the imaging community across generations as Bracco strongly believes knowledge sharing contributes to medical progress. As new generations and technologies come about, the need for education is paramount.
The Applied Radiology “Leaders on the Horizon” Residency Program, which Bracco supports through an unrestricted educational grant, provides scholarships to six radiology resident applicants whose submitted research papers (three clinical research papers and three clinical review articles) are selected for publication by Applied Radiology. These distinguished individuals will be honored at an evening reception hosted by Applied Radiology during RSNA 2024.
Bracco is also proud to enter the fifth year of its 10-year commitment to donate $450,000 to the RSNA Research & Education Foundation. “At this year’s RSNA meeting, we are again pleased to demonstrate our unwavering commitment to our customers and the industry. As a global leader in imaging our singular focus is to improve people's lives by shaping the future of prevention and precision imaging,” said Cosimo De Pinto, Senior Vice President of Sales and Marketing at Bracco Diagnostics Inc. “We are proud to strengthen the radiology community through our strategic collaborations, which allow our company to bring cutting-edge practical solutions to the market.”
Visit Bracco’s Booth (#3300): Bracco’s booth experience will highlight its four pillars:
- Innovation: Bracco is embracing the era of precision medicine through continuous innovation, as demonstrated by its latest product advancements.
- Education: Bracco continues its tradition of nurturing education because the value of knowledge lies in sharing.
- Sustainability: which is built into everything Bracco does: caring for the patient, the medical ecosystem, and the future of the planet.
- Trust: the driving force strengthening Bracco’s bond within the industry.
Throughout the RSNA conference, short presentations on each of these pillars will be delivered live at their booth throughout the day.
Connect with Bracco on LinkedIn and follow #BraccoImaging for more RSNA news.